Tumor regression and sirolimus-based therapy in lung transplantation

Journal of Heart and Lung Transplantation

Volumn 32, Issue 9, 2013, Pages 938-939

  Hillen, Uwe ^a   Griewank, Klaus ^a   Sommerwerck, Urte ^b   Baba, Hideo A ^c   Schadendorf, Dirk ^a  

^a West German Cancer Center   (Germany)

^b RUHRLANDKLINIK   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; MAMMALIAN TARGET OF RAPAMYCIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; CANCER REGRESSION; CASE REPORT; EXCISION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MALE; NOTE; PRIORITY JOURNAL; SCALP; SIGNAL TRANSDUCTION; SKIN CARCINOMA; SKIN NODULE;

ANTINEOPLASTIC AGENTS; CALCINEURIN; CARCINOMA, SQUAMOUS CELL; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; SIROLIMUS; SKIN NEOPLASMS; TACROLIMUS; TREATMENT OUTCOME;

EID: 84881582276     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2013.06.022     Document Type: Letter

References (5)

1. C. Ulrich, J. Kanitakis, E. Stockfleth, and S. Euvrard Skin cancer in organ transplant recipients - where do we stand today? Am J Transplant 8 2008 2192 2198
2. M. Alam, and D. Ratner Cutaneous squamous-cell carcinoma N Engl J Med 344 2001 975 983
3. S. Euvrard, E. Morelon, and L. Rostaing Sirolimus and secondary skin-cancer prevention in kidney transplantation N Engl J Med 367 2012 329 339
4. G. Stallone, A. Schena, and B. Infante Sirolimus for Kaposi's sarcoma in renal-transplant recipients N Engl J Med 352 2005 1317 1323
5. A. Gutiérrez-Dalmau, I. Revuelta, and B. Ferrer Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations Transplantation 90 2010 986 992